Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/dom.13203 http://scihub22266oqcxt.onion/10.1111/dom.13203 C5947669!5947669!29369493     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Diabetes+Obes+Metab 2018 ; 20 (5): 1140-7 Nephropedia Template TP {{tp|p=29369493|t=2018. Injecting without pressing a button: An exploratory study of a shield?triggered injection mechanism |pdf=|usr=}}{{29369493}} gab.com Text Injecting without pressing a button: An exploratory study of a shield triggered injection mechanism JO: Diabetes Obes Metab http://www.kidney.de/pget.php?&tw=1&pmid=29369493 #FOAvip Aims: To evaluate the injection success and user perception of a shield?triggered pen?injector mechanism. Methods: The trial (http://ClinicalTrials.gov NCT02627287) was an exploratory, two?centre, one?visit, open?label, randomized controlled trial conducted in Germany in 150 injection?experienced individuals with type 1 or type 2 diabetes. Participants self?administered subcutaneous injections of a placebo solution using a prototype shield?triggered pen?injector, DV3316 (Novo Nordisk, Bagsvaerd, Denmark), and FlexPen (Novo Nordisk, Bagsvaerd, Denmark). Injection success was evaluated on a yes/no basis by the investigator. Participant confidence, leakage of fluid and pain were evaluated after each injection. Pain and device experience were assessed after completion of all injections with each pen?injector. Overall preference was assessed after completion of all injections with both pen?injectors. Results: Injection success was high with both pen?injectors (97.0%, DV3316 vs 99.7%, FlexPen). Participant confidence in dose delivery was similar for the two devices (88% of injections with DV3316 vs 81% with FlexPen were scored as ?extremely confident?). The median injection pain score on a visual analogue scale (0?100) was 3 with DV3316 vs 4 with FlexPen after each injection, and 4 with DV3316 vs 5 with FlexPen after all injections with each device. After all injections were completed, 55% of participants reported an overall preference for DV3316 vs 21% for FlexPen. Conclusion: This study demonstrates that injection?experienced individuals can achieve a high injection success rate with a shield?triggered pen?injector, with similar patient confidence and injection pain compared with FlexPen. Twit Text FOAVip Injecting without pressing a button: An exploratory study of a shield triggered injection mechanism ????Diabetes Obes Metab http://www.kidney.de/pget.php?&tw=1&pmid=29369493 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29369493 #FOAvip English Wikipedia <ref>{{Cite pmid|29369493}}</ref> Injecting without pressing a button: An exploratory study of a shield?triggered injection mechanism #MMPMID29369493 Zijlstra E; Coester H; Heise T; Plum?Mörschel L; Rasmussen O; Rikte T; Pedersen LK; Qvist M; Sparre T Diabetes Obes Metab 2018[May]; 20 (5): 1140-7 PMID29369493show ga Aims: To evaluate the injection success and user perception of a shield?triggered pen?injector mechanism. Methods: The trial (http://ClinicalTrials.gov NCT02627287) was an exploratory, two?centre, one?visit, open?label, randomized controlled trial conducted in Germany in 150 injection?experienced individuals with type 1 or type 2 diabetes. Participants self?administered subcutaneous injections of a placebo solution using a prototype shield?triggered pen?injector, DV3316 (Novo Nordisk, Bagsvaerd, Denmark), and FlexPen (Novo Nordisk, Bagsvaerd, Denmark). Injection success was evaluated on a yes/no basis by the investigator. Participant confidence, leakage of fluid and pain were evaluated after each injection. Pain and device experience were assessed after completion of all injections with each pen?injector. Overall preference was assessed after completion of all injections with both pen?injectors. Results: Injection success was high with both pen?injectors (97.0%, DV3316 vs 99.7%, FlexPen). Participant confidence in dose delivery was similar for the two devices (88% of injections with DV3316 vs 81% with FlexPen were scored as ?extremely confident?). The median injection pain score on a visual analogue scale (0?100) was 3 with DV3316 vs 4 with FlexPen after each injection, and 4 with DV3316 vs 5 with FlexPen after all injections with each device. After all injections were completed, 55% of participants reported an overall preference for DV3316 vs 21% for FlexPen. Conclusion: This study demonstrates that injection?experienced individuals can achieve a high injection success rate with a shield?triggered pen?injector, with similar patient confidence and injection pain compared with FlexPen. äInjecting without pressing a button: An exploratory study of a shield?(epmc).pdf DeepDyve Pubget Overpricing